Daewon Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	219,264	256,130	305,427	331,930	393,197	342,999
Market Cap Growth	-27.45%	-16.14%	-7.99%	-15.58%	14.64%	-9.91%
Enterprise Value	353,483	409,009	434,054	418,509	453,068	412,231
Last Close Price	10230.00	11950.00	13957.75	15014.55	17630.58	14913.94
PE Ratio	-	-	21.49	13.88	12.31	49.08
Forward PE	28.82	9.77	9.77	9.77	9.77	9.77
PS Ratio	0.36	0.42	0.51	0.63	0.82	0.97
PB Ratio	0.80	0.93	1.07	1.26	1.58	1.57
P/TBV Ratio	0.96	1.12	1.27	1.37	1.74	1.77
P/FCF Ratio	17.52	20.47	-	8.41	21.36	18.73
P/OCF Ratio	5.18	6.05	10.17	6.42	14.89	15.30
PEG Ratio	0.74	0.49	0.49	0.49	0.49	0.49
EV/Sales Ratio	0.58	0.68	0.73	0.79	0.95	1.16
EV/EBITDA Ratio	12.66	15.02	9.28	8.40	7.28	11.11
EV/EBIT Ratio	84.80	117.39	16.27	12.98	10.56	21.36
EV/FCF Ratio	28.25	32.69	-	10.61	24.62	22.52
Debt / Equity Ratio	0.74	0.74	0.66	0.55	0.47	0.57
Debt / EBITDA Ratio	7.42	7.42	4.00	2.93	1.87	3.34
Debt / FCF Ratio	16.15	16.15	-	3.70	6.33	6.77
Net Debt / Equity Ratio	0.46	0.46	0.50	0.44	0.28	0.32
Net Debt / EBITDA Ratio	4.61	4.61	3.02	2.33	1.12	1.86
Net Debt / FCF Ratio	10.04	10.04	-29.22	2.94	3.78	3.78
Asset Turnover	1.01	1.01	1.10	1.10	1.09	0.93
Inventory Turnover	3.17	3.17	2.86	2.76	3.01	2.69
Quick Ratio	0.72	0.72	0.62	0.56	0.89	1.07
Current Ratio	1.19	1.19	1.19	1.15	1.62	1.77
Return on Equity (ROE)	-0.79%	-0.79%	3.68%	9.15%	13.13%	3.07%
Return on Assets (ROA)	0.36%	0.36%	3.06%	4.19%	6.07%	3.16%
Return on Invested Capital (ROIC)	-0.75%	-0.73%	4.14%	8.38%	11.21%	2.75%
Return on Capital Employed (ROCE)	0.90%	0.90%	7.00%	9.90%	13.20%	5.90%
Earnings Yield	-0.63%	-0.54%	4.65%	7.21%	8.12%	2.04%
FCF Yield	5.71%	4.88%	-1.58%	11.88%	4.68%	5.34%
Dividend Yield	2.93%	-	-	-	-	1.30%
Payout Ratio	-	-	44.75%	30.69%	12.90%	44.93%
Buyback Yield / Dilution	-0.67%	-0.67%	1.71%	0.98%	-3.09%	0.58%
Total Shareholder Return	2.25%	-0.67%	1.71%	0.98%	-3.09%	1.88%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.